Arcellx, Inc. (ACLX)
NASDAQ: ACLX · Real-Time Price · USD
68.57
+0.02 (0.03%)
At close: Jan 27, 2026, 4:00 PM EST
68.51
-0.06 (-0.09%)
After-hours: Jan 27, 2026, 5:57 PM EST
Arcellx Market Cap
Arcellx has a market cap or net worth of $3.96 billion as of January 27, 2026. Its market cap has increased by 6.05% in one year.
Market Cap
3.96B
Enterprise Value
3.44B
1-Year Change
6.05%
Ranking
Category
Stock Price
$68.57
Market Cap Chart
Since the IPO on February 4, 2022, Arcellx's market cap has increased from $503.15M to $3.96B, an increase of 687.32%. That is a compound annual growth rate of 67.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 3.96B | 5.08% |
| Dec 31, 2025 | 3.77B | -9.09% |
| Dec 31, 2024 | 4.15B | 43.89% |
| Dec 29, 2023 | 2.88B | 112.13% |
| Dec 30, 2022 | 1.36B | 170.02% |
| Feb 4, 2022 | 503.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TG Therapeutics | 4.49B |
| Amicus Therapeutics | 4.42B |
| CG Oncology | 4.30B |
| ADMA Biologics | 4.04B |
| Ligand Pharmaceuticals | 3.90B |
| Centessa Pharmaceuticals | 3.76B |
| Terns Pharmaceuticals | 3.75B |
| Liquidia | 3.67B |